Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06235008

PAthwAy of Dyspneic patIent in Emergency in the North-east Region (North-East PArADIsE)

This is an observational retrospective multi-center study in patients managed for acute dyspnea by Emergency department medical team.

The main aim of the study is to evaluate factors associated with mortality risks in patients managed for acute dyspnea by an Emergency department medical team, overall, as well as in subgroups of interest (male/female, age categories, mode of admission and comorbidities).

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Dyspnea Pathological Conditions, Signs and Symptoms Respiration Disorders Respiratory Tract Diseases Signs and Symptoms Signs and Symptoms, Respiratory

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Man or women ≥ 18 years
  • Patients with acute dyspnea cared by a medical team of the emergencies of CHRU of Nancy, CHR Metz-Thionville and CH d'Epinal.

Exclusion criteria

  • Cardiorespiratory arrest before medical management by the Emergency Department team
  • Adults under legal protection

Treatment and study plan

Primary outcomes

  1. All-cause mortality

    Time frame: Within 5 years following hospital discharge

Secondary outcomes

  1. Main diagnosis during the initial hospitalization

    Time frame: Within hospital stay, maximum 21 days

  2. Mismatch between diagnosis in the Emergency department and at discharge

    Time frame: Within hospital stay, maximum 21 days

    Difference between the diagnosis reported in the Emergency department file and the diagnosis reported at hospital discharge.

  3. Length of hospital stay

    Time frame: Within hospital stay, maximum 21 days

  4. Administration of non-invasive ventilation

    Time frame: Within hospital stay, maximum 21 days

  5. Timing of non-invasive ventilation

    Time frame: Within hospital stay, maximum 21 days

  6. Administration of diuretics

    Time frame: Within hospital stay, maximum 21 days

  7. Timing of diuretics

    Time frame: Within hospital stay, maximum 21 days

  8. Post emergency admission

    Time frame: Within hospital stay, maximum 21 days

    Type of department admitting the patient following emergency care (intensive care unit, cardiology unit, cardiac intensive care unit, post-emergency department, other...)

  9. All-cause hospital mortality

    Time frame: Within hospital stay, maximum 30 days

  10. Readmissions (all-cause and related to acute dyspnea) to the emergency department

    Time frame: Within 5 years after admission

  11. Congestion score

    Time frame: Within 2 days of admission

    Assessed by: Congestion score assessed on chest X-ray on admission to the emergency department. The congestion score ranges from 0 (indicating no congestion signs) to 3 (indicating intense congestion).

Study contacts

Contact information is provided by the study sponsor or research team.

GIRERD Nicolas

CONTACT

[email protected]

0383157322 ext. +33

Sponsors and collaborators

Lead sponsor

Pr. Nicolas GIRERD

Other

Registry information

Official study title

PAthwAy of Dyspneic patIent in Emergency in the North-east Region

Acronym: N_E_PARADISE

Important dates

Study start
2024
Primary completion
2029
Study completion
2030
First posted
Jan 31, 2024
Registry last updated
Jan 31, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.